UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria, Virginia 2231371450
`www.uspto.gov
`
`15/431,462
`
`02/13/2017
`
`LEI HUANG
`
`731156.583C1
`
`8970
`
`Seed IP Law Group LLP/Panason1e
`701 Fifth Avenue, Suite 5400
`Seattle, WA 98104
`
`RIVAS' SALVADOR E
`
`ART UNIT
`
`2413
`
`PAPER NUMBER
`
`NOTIFICATION DATE
`
`DELIVERY MODE
`
`02/ 1 8/2020
`
`ELECTRONIC
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`The time period for reply, if any, is set in the attached communication.
`
`Notice of the Office communication was sent electronically on above—indicated "Notification Date" to the
`
`following e—mail address(es):
`US PTOeACtion @ SeedIP .Com
`
`pairlinkdktg @ seedip .eom
`
`PTOL-90A (Rev. 04/07)
`
`

`

`"act
`
`IV , CofA/led b'l'
`””09 0
`””3 ’ ”7
`
`Application No.
`
`15/431,462
`Examiner
`SALVADOR E RIVAS
`
`Applicant(s)
`
`HUANG, LEI
`Art Unit
`2413
`
`AIA (FITF) Status
`Yes
`
`- The MAILING DA TE of this communication appears on the cover sheet wit/7 the correspondence address-
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application. If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL-85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1.. This communication is responsive to Applicant's remarks and claims filed on 10/29/19.
`
`[:1 A declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/were filed on
`
`2:] An election was made by the applicant in response to a restriction requirement set forth during the interview on
`restriction requirement and election have been incorporated into this action.
`
`; the
`
`3.. The allowed cIaim(s) is/are 1-3,10,13-15 are renumbered # 1-7 . As a result of the allowed cIaim(s), you may be eligible to benefit
`from the Patent Prosecution Highway program at a participating intellectual property office for the corresponding application. For
`more information, please see http://www.uspto.gov/patents/init_events/pph/index.jsp or send an inquiry to
`PPeredback@uspto.gov.
`
`4.. Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119( )-(d) or (f).
`
`Certified copies:
`
`a) .All
`
`b) [3 Some
`
`*0) C] None of the:
`
`1.
`
`Certified copies of the priority documents have been received.
`
`2. D Certified copies of the priority documents have been received in Application No.
`
`3. D Copies of the certified copies of the priority documents have been received in this national stage application from the
`International Bureau (PCT Rule 17.2( )).
`
`* Certified copies not received:
`
`Applicant has THREE MONTHS FROM THE “MAILING DATE“ of this communication to file a reply complying with the requirements
`noted below. Failure to timely comply will result in ABANDONMENT of this application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`
`51:] CORRECTED DRAWINGS (as “replacement sheets“) must be submitted.
`C]
`including changes required by the attached Examiner's Amendment / Comment or in the Office action of
`Paper No./Mai| Date
`Identifying indicia such as the application number (see 37 CFR 1.84(c)) should be written on the drawings in the front (not the back) of each
`sheet. Replacement sheet(s) should be labeled as such in the header according to 37 CFR 1.121(d).
`
`6C] DEPOSIT OF and/or INFORMATION about the deposit of BIOLOGICAL MATERIAL must be submitted. Note the
`attached Examiner's comment regarding REQUIREMENT FOR THE DEPOSIT OF BIOLOGICAL MATERIAL.
`
`Primary Examiner, Art Unit 2413
`
`Attachment(s)
`LU Notice of References Cited (PTO-892)
`
`2.[:] Information Disclosure Statements (PTO/SB/08),
`Paper No./Mai| Date
`.
`3C] Examiner's Comment Regarding Requirement for Deposit
`of Biological Material
`.
`4.. Interview Summary (PTO-413)
`Paper No./Mai| Date. 20200211.
`/SALVADOR E RIVAS/
`
`5. U Examiner's Amendment/Comment
`
`6. C] Examiner's Statement of Reasons for Allowance
`
`7. [:1 Other
`
`U.S. Patent and Trademark Office
`PTOL-37 (Rev. 08-13)
`
`Notice of Allowability
`
`_
`Part of Paper N0-/Mall Date 20200211
`
`